Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A study of adjuvant chemotherapy for malignant glioma
ISRCTN ISRCTN81218776
DOI 10.1186/ISRCTN81218776
ClinicalTrials.gov identifier
EudraCT number
Public title A study of adjuvant chemotherapy for malignant glioma
Scientific title
Acronym N/A
Serial number at source BR05
Study hypothesis To assess whether the addition of chemotherapy to a standard radiotherapy regime influences the survival of adult patients with malignant glioma (astrocytomas grades 3 & 4) and to assess the ability of in vitro chemosensitivity testing to identify patients with a better prognosis.
Lay summary http://www.ctu.mrc.ac.uk/research_areas/study_details.aspx?s=101
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer
Participants - inclusion criteria 1. Age 18-69
2. No previous treatment except surgery, corticosteroids, anticonvulsants or diuretics
3. Entry within 6 weeks of surgery
4. Other malignancies
5. Fitness for treatment
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/09/1988
Anticipated end date 30/06/1996
Status of trial Completed
Patient information material
Target number of participants 600
Interventions 1. One group receives chemotherapy added to a standard radiotherapy regimen
2. The other group receives none
Primary outcome measure(s) Survival time
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications 2001 results in http://www.ncbi.nlm.nih.gov/pubmed/11208845
Contact name Dr  Hannah  Brooks
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 28/02/2001
Last edited 12/04/2012
Date ISRCTN assigned 28/02/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.